Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial

BACKGROUND: There is an urgent need for an effective tuberculosis (TB) vaccine. Heterologous prime–boost regimens induce potent cellular immunity. MVA85A is a candidate TB vaccine. This phase I clinical trial was designed to evaluate whether alternating aerosol and intradermal vaccination routes wou...

Descripción completa

Detalles Bibliográficos
Autores principales: Manjaly Thomas, Zita-Rose, Satti, Iman, Marshall, Julia L., Harris, Stephanie A., Lopez Ramon, Raquel, Hamidi, Ali, Minhinnick, Alice, Riste, Michael, Stockdale, Lisa, Lawrie, Alison M., Vermaak, Samantha, Wilkie, Morven, Bettinson, Henry, McShane, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490884/
https://www.ncbi.nlm.nih.gov/pubmed/31039172
http://dx.doi.org/10.1371/journal.pmed.1002790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490884/
https://www.ncbi.nlm.nih.gov/pubmed/31039172
http://dx.doi.org/10.1371/journal.pmed.1002790

Ejemplares similares